Aquestive Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Issued FY24 Revenue Guidance Above Estimates.
Aquestive Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Issued FY24 Revenue Guidance Above Estimates.
Aquestive Therapeutics股价上涨，因该公司发布了Q2财报，收入超过预期，并发布了FY24营业收入指引高于预期。
Aquestive Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results and Issued FY24 Revenue Guidance Above Estimates.
Aquestive Therapeutics股价上涨，因该公司发布了Q2财报，收入超过预期，并发布了FY24营业收入指引高于预期。